PRZOOM - /newswire/ -
London, United Kingdom, 2007/09/07 - Recent innovations from Creganna Medical Devices PoleVault™, MicroFlex™ and Fusion Technology™ have significantly enhanced delivery systems for minimally invasive surgery devices and assisted medical device manufacturers improve outcomes for patients.
“The PoleVault™ hypotube with its 40% more kink resistance than other hypotubes increases physicians success during a stent placement procedure by enabling them to navigate more difficult anatomies and decreasing the risk of catheter failure in use,” notes Frost & Sullivan Research Analyst Sowmya Rajagopalan. “Medical device manufacturers can employ the product to reduce catheter wall thickness thereby enabling smaller device sizes. The PoleVault™ Hypotube had an adoption rate as high as 30 per cent during its launch period.”
As the frontiers of minimally invasive medicine advance, new procedures are emerging for the treatment of the body’s most challenging vasculatures such as the small and intricate vascular system of the brain. However, such interventions require a new set of device technologies to ensure successful outcomes.
Leading the way with enabling technologies, Creganna launched MicroFlex™ – a one-piece micro tube of variable flexibility optimised for small vasculature navigation. MicroFlex™ overcomes the design challenges and higher costs associated with the traditional design approach of multi-piece assemblies.
Fusion Technology™, the capability to weld Nitinol to Stainless Steel tubing, is a ground breaking innovation utilising patented technology†. Fusion Technology™ demonstrates a strong weld zone, not achieved by other welding and joining techniques and enables delivery system design that is both cost effective and displays optimal performance.
“Creganna’s Fusion Technology™ is especially significant as Nitinol is universally recognized by material scientists as an exceptionally difficult material to join to other materials,” says Sowmya Rajagopalan. “Considering this and the other aforementioned advances, Frost & Sullivan is proud to present the 2007 Technology Innovation of the Year Award to Creganna Medical Devices.”
Each year Frost & Sullivan presents this award to the company that has demonstrated technological superiority within its industry. This award recognises Creganna’s ability to successfully develop and introduce new technologies, formulate a well-designed product family and make significant product performance contributions to the industry.
The 2007 Medical Device Technology Innovation of the Year Award will be presented to Creganna at Frost and Sullivan’s Awards Banquet to be held in Dublin on the 3rd October next. Ranked among the global Top 10 outsourcing providers to the medical device industry and listed in Europe’s top 500 growth companies, Creganna is the only Irish company ever to receive this award in this category.
About Creganna Medical Devices
Creganna Medical Devices (creganna.com) provides products and services to medical device manufacturers worldwide. Creganna’s expertise is in the design, development and manufacture of delivery device shafts used in catheter-based minimally invasive procedures. Creganna is based in Galway, Ireland and Marlborough, MA USA. Creganna has a leading position in its market and is ranked among the Top 10 global outsourcing providers to the medical device industry.
About Frost & Sullivan
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics and demographics.
Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research in order to identify best practices in the industry.
† US Patent: 6,875,949/EWI